MMP9 and endometrial carcinoma: A significantly higher percentage of slides showed high immunoreactivity with MMP-9 in grade 2 (28.6%), grade 3 (33.3%), endometrial serous (57.1%), and undifferentiated endometrial carcinomas (100%) when compared to the proliferative endometrium (0%) (p < 0.05).